Norbert Riedel, Director at Ariad, holds 162.15K shares in Eton Pharmaceuticals (Ticker: ETON), holds 15.95K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 0.00 shares in Cerevel Therapeutics Holdings (Ticker: CERE).
Norbert Riedel latest transaction was an Uninformative Buy of $373.84K.
What was Norbert Riedel's most profitable transaction?
Norbert Riedel’s most profitable transaction was an Informative Sell of JAZZ stock on August 11, 2015. The return on the trade was 22.70%.
What is Norbert Riedel's role in Ariad?
Norbert Riedel's role in Ariad is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.